PuraMed BioScience®, Inc., Launches a Marketing Blitz for LipiGesic® M, Its Clinically-Tested Migraine Pain Reliever in the Denver CO Region to Coincide with the NACDS’s Marketplace 2012 Trade Convention
(Schofield WI – June 12, 2012) – PuraMed BioScience®, Inc., (OTCBB:PMBS) announced today that they will be attending NACDS’s tradeshow, Marketplace 2012, being held in Denver Colorado between June 23- 26, 2012. In conjunction with the event, PuraMed BioScience is implementing a media blitz for LipiGesic® M, which has been clinically tested by leading US [...]


Studies show that LipiGesic M works as well as prescription migraine medication. LipiGesic M has been declared a highly effective, first-line treatment for acute migraine pain.